Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Enhancement of hypoxia-activated prodrug TH-302 anti-tumor activity by Chk1 inhibition

Figure 1

Enhanced TH-302 cytotoxicity by Chk1 inhibitors was observed in p53-mutant HT29 cells. HT29 cells were seeded for 24 h, and then exposed to TH-302 alone, or combined with 0.1 μM of AZD7762 (A), 0.5 μM LY2603618 (B), or 0.4 μM PF477736 (C) for 2 h under either air (21% O2) or hypoxia (N2). After wash, cells were treated with the Chk1 inhibitors for an additional 70 h under air (21% O2). The viable cells were detected using AlamarBlue and quantified with spectrophotometer. IC50 values are presented in Table 1. Combination indexes from Chou-Talalay (CalcuSyn) analyses are presented in Table 2 (air group and N2 group). The data are the representative of four independent experiments.

Back to article page